宫颈癌前病变和宫颈癌组织中凋亡相关基因survivin的表达及其与人乳头状瘤病毒感染的关系

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (10): 1276-1279.

宫颈癌前病变和宫颈癌组织中凋亡相关基因survivin的表达及其与人乳头状瘤病毒感染的关系

郎雁¹, 熊永炎¹, 陈惠桢²

1. 武汉大学中南医院病理科, 湖北, 武汉, 430010;
2. 武汉大学中南医院妇瘤科, 湖北, 武汉, 430010

出版日期:2005-10-20 发布日期:2005-10-20
基金资助:
收稿日期:2005-3-28。
作者简介:郎雁(1968- ),女,在读硕士研究生,主治医师,电话:027-83930433,E-mail:babyjulialang@126.com

Association between expression of survivin and high-risk human papillomavirus infection in cervical cancer and precancerous tissues

LANG Yan¹, XIONG Yong-yan¹, CHEN Hui-zhen²

1. 武汉大学中南医院病理科, 湖北, 武汉, 430010;
2. 武汉大学中南医院妇瘤科, 湖北, 武汉, 430010

Online:2005-10-20 Published:2005-10-20

摘要/Abstract

摘要： 目的探讨凋亡相关基因survivin在宫颈癌前病变和宫颈癌组织中的表达及其与人乳头状瘤病毒(HPV)感染的相关性。方法选取76例宫颈癌前病变或宫颈癌患者,另取10例正常宫颈组织作为对照。应用免疫组织化学SP法检测各组宫颈组织中凋亡相关基因survivin的表达;设计高危型HPV(HPV16,18,31,33,58等)通用引物,以touch-downPCR法检测各组宫颈组织中高危型HPV的感染率。结果 (1)从正常宫颈→癌前病变→宫颈癌,survivin表达逐渐增强(P<0.05);(2)survivin表达与宫颈癌组织学分级有关(P<0.05),而与年龄、临床分期及组织学分型无关(P>0.05);(3)从正常宫颈→癌前病变→宫颈癌,高危型HPV阳性率逐渐升高(P<0.05);(4)高危型HPV感染率在不同年龄、临床分期、组织学分级及组织学分型中,均无统计学差异(P>0.05);(5)survivin与高危型HPV在宫颈癌组织中的表达呈正相关(P<0.05)。结论 survivin表达及高危型HPV感染可能与宫颈癌的发生、发展密切相关,两者在宫颈癌的发病机制中可能起着协同作用。

Abstract: Objective To investigate the expression of survivin and its association with high-risk human papillomavirus (HPV) infection in cervical cancer and precancerous tissues. Methods In 76 patients with cervical intraepithelial neoplasia (CIN) or cervical carcinoma, the expression of survivin was detected by immunohistochemistry and the infection rates of high-risk HPV including HPV16, 18, 31, 33, 52, and 58 were assayed by touch-down PCR, with 10 cases of normal cervical specimens serving as the control. Results Survivin expression tended to increase along with the tumor progression (P<0.05), and was associated with the histological grade of invasive carcinoma (P<0.05) but not with the patients’ age, clinical stage or histological classification (P>0.05). The positivity rate of high-risk HPV increased only in association with tumor progression (P<0.05) but not with the patients’ age, clinical stage or histological classification (P>0.05). Positive correlation between the expression of survivin and high-risk HPV infection was observed in cervical carcinoma. Conclusion Survivin might play an important role in the occurrence and development of cervical carcinoma in coordination with high-risk HPV.

中图分类号:

R737.33

郎雁¹, 熊永炎¹, 陈惠桢². 宫颈癌前病变和宫颈癌组织中凋亡相关基因survivin的表达及其与人乳头状瘤病毒感染的关系[J]. 南方医科大学学报, 2005, 25(10): 1276-1279.

LANG Yan¹, XIONG Yong-yan¹, CHEN Hui-zhen². Association between expression of survivin and high-risk human papillomavirus infection in cervical cancer and precancerous tissues[J]. Journal of Southern Medical University, 2005, 25(10): 1276-1279.

参考文献

[1] 连利娟.林巧稚妇科肿瘤学[M].第3版,北京:人民卫生出版社,2000.209.
[2] Yoshinouch M, Hongo A, Kamoto N, et al. Alteration of the CDKN2/P16 gene is not required for HPV-positive uterine cervical cancer cell lines[J]. Iht J Oncol, 2000, 16(3): 537-41.
[3] Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, surviving, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line[J]. Lab Invest, 1999, 79(9): 1121-6.
[4] Kim HS, Shiraki K, Rark SH, et al. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix [J].Anticancer Res, 2002, 22(2A): 805-8.
[5] 王梅,王冰,王晓丽,等.凋亡相关基因survivin在子宫颈癌组织中的表达及其与bcl-2、p53基因表达相关性的初步研究[J].中华妇产科杂志,2001,36(9):546-8.Wang M, Wang B, Wang XL, et al. A novel antiapoptosis gene,survivin, bcl-2, p53 expressed in cervical carcinoma [J]. Chin J Obstet Gynecol, 2001, 36(9): 546-8.
[6] 郑洪,侯文,胡琼.凋亡调控因子survivin和Caspase-3在宫颈上皮内瘤样变及宫颈癌中的表达及意义[J].贵州医药,2003,27(2):105-7.Zheng H, Hou W, Hu Q. Expression of apoptotic regulators surviving and effect or caspase-3 in cervical carcinoma and cervical intraepithelial neoplasia [J]. Guizhou Med J, 2003, 27(2): 105-7.
[7] Yoshida H, Sumi T, Hyum Y, et al. Expression of survivin and metrixmetalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix[J]. Oncol Rep, 2003, 10(1): 45-9.
[8] 徐成康,梅卓贤.宫颈人类乳头状病毒感染的筛查及其意义[J].中山医科大学学报,1998,19(3):223-6.Xu CK, Mei ZX. Screening of human papilloma virus infection in cervix and its significance[J]. Acad J SUMS, 1998, 19(3): 223-6.
[9] Burd EM. Human papillomavirus and cervical carcer [J]. Clin Microbiol Rev, 2003, 16(1): 1-17.
[10] Arends MJ, Yvonne K, Donaldson YK, et al. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16[J]. Pathology, 1993, 24(4): 432-7.
[11] Frost M, Jarboe EA, Orlicky D, et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma[J]. Am J Clin Pathol, 2002, 117(5): 738-44.

[1]	郑军生；谢有科；钟雪云； . HCG-α、HCG-β和COX-2在子宫内膜不典型增生与子宫内膜癌的表达[J]. 南方医科大学学报, 2006, 26(12): 1772-1773.
[2]	张瑜；张怡；林秋华；. 孕激素对人子宫内膜癌细胞系Ishikawa影响的蛋白质组学研究[J]. 南方医科大学学报, 2006, 26(08): 1110-1113.
[3]	卢金利；杨芳；. 宫颈癌中顺铂放疗增敏的临床药代动力学机制[J]. 南方医科大学学报, 2006, 26(08): 1170-1172.
[4]	绿宝明；. 子宫颈腺癌86例临床及预后分析[J]. 南方医科大学学报, 2006, 26(08): 1248-1249.
[5]	郭遂群；邢福祺；庞占军；方唯意；刘国炳；. 子宫内膜癌I型和II型全基因表达谱初步分析[J]. 南方医科大学学报, 2006, 26(06): 734-737.
[6]	王莹;李旭;陈葳;. 抗人宫颈癌单链抗体的表达、结构预测和功能分析[J]. 南方医科大学学报, 2006, 26(01): 16-21.
[7]	刘国炳, 刘欣, 庞战军, 邢福祺. 宫颈癌患者盆腔淋巴结HPV-DNA检测的临床意义[J]. 南方医科大学学报, 2005, 25(10): 1236-1239.
[8]	刘欣, 刘国炳, 庞战军, 邢福祺. 宫颈癌组织中HPV16E7序列多态性分析[J]. 南方医科大学学报, 2005, 25(10): 1272-1275.
[9]	赵恩锋¹, 鲍嫘², 李超, 宋磊³, 李亚里¹. 近50年宫颈癌的发病趋势和临床特点分析[J]. 南方医科大学学报, 2005, 25(06): 605-609.
[10]	郑小康¹, 陈龙华¹, 李健². 大菜花型宫颈癌的放疗效果及预后分析[J]. 南方医科大学学报, 2005, 25(03): 332-334,338.
[11]	周瑾¹, 陈士岭¹, 邢福祺¹, 庞战军¹, 李冰², 周问渠², 付欣², 丁彦青³. 葡萄胎发病新基因F10与滋养细胞肿瘤侵袭相关性研究[J]. 南方医科大学学报, 2005, 25(02): 171-173.
[12]	刘国炳, 庞占军. 两对姐妹患子宫内膜癌临床诊治分析[J]. 南方医科大学学报, 2005, 25(02): 239-240.
[13]	刘柯¹, 王莉丽², 孙芳¹, 郑燕芳³, 张积仁³. 抗HPV16E6核酶对宫颈癌CaSKi细胞增殖和侵袭力的影响[J]. 南方医科大学学报, 2004, 24(12): 1367-1372.
[14]	周瑞丽, 刘国炳. 宫颈癌发病年龄与预后的关系(附93例分析)[J]. 南方医科大学学报, 2004, 24(09): 1066-1067.
[15]	张广亮¹, 刘国炳¹, 黄琦丽², 邢福祺¹. 腹腔镜与开腹子宫肌瘤剜除术氧化应激状态的比较[J]. 南方医科大学学报, 2004, 24(08): 907-909.